Drug
Teriflunomide
Teriflunomide: highest development phase Phase 3, developed by Merck. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Merck
Trials
| Drug | Phase | Indication |
|---|---|---|
| Teriflunomide NCT04338022 | Phase 3 | Relapsing Multiple Sclerosis |
Latest
No recent events.
Follow Teriflunomide on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.